Searchable abstracts of presentations at key conferences in endocrinology

ea0065p270 | Neuroendocrinology | SFEBES2019

Antisense oligonucleotides as a novel medical therapy for Cushing’s disease

Whatmore Jacob , Alzahrani Ahmed , Porter Julie , Kemp Helen , Newell-Price John

Introduction: Cushing’s disease (CD) is a rare but devastating condition, caused by hypersecretion of adrenocorticotropic hormone (ACTH) from a corticotroph adenoma in the anterior pituitary. CD is associated with a five-fold excess mortality and clinical features including hypertension, diabetes mellitus, osteoporosis, and depression. First-line treatment is transsphenoidal surgery, but this is effective in only 65% of cases and the relapse rate is high. Other treatment ...

ea0059p125 | Neuroendocrinology and pituitary | SFEBES2018

Anti-POMC siRNA reduces ACTH secretion in an in vitro model of Cushing’s disease

Alzahrani Ahmed , Foulkes Elizabeth , Porter Julie , Kemp Elizabeth , Newell-Price John

Context: Cushing’s disease (CD) results from the release of high levels of adrenocorticotrophic hormone (ACTH) from a pituitary adenoma. Increased ACTH secretion stimulates excess cortisol production, causing weight gain, hypertension, diabetes and depression. The only curative treatment is transsphenoidal surgery, but the rate of recurrence is high and there is a lack of suitable medical therapies. RNA-interference is a mechanism of post-transcriptional gene silencing th...